ReNerve Signs Exclusive Partnership with Leading Distributor in Hong Kong to Accelerate International Expansion

Highlights:
● ReNerve Limited has partnered with Accession Medical Supplies Co in an exclusive distribution
agreement for sales and marketing in Hong Kong and Macau
● The agreement with Accession marks ReNerve’s further expansion into the Asian market for the
Company’s primary product, the NervAlign® Nerve Cuff
● The NervAlign® Nerve Cuff is an FDA cleared product for use on damaged or transected nerves with
no gaps or gap closure achieved by flexion
● ReNerve has submitted its application for regulatory approval in Hong Kong
● ReNerve will leverage Accession’s existing relationships with local hospitals and surgeons to drive
sales, which in turn will assist in gaining regulatory approval and act as a gateway to the broader
Greater Bay Area
● The Global Nerve Repair Biomaterials Market was valued at USD$1.96 billion in 2024 and is projected
to grow at a CAGR of 17.8% from 2024 to 2031 to USD$6.19 billion1.